Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zsolt Gabos

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
JAMA Oncology|September 19, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical TrialAnand Swaminath, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2025
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE TrialQirui Hou, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP TrialDevin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
JAMA Oncology|September 19, 2024
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non-Small Cell Lung Cancer: The LUSTRE Phase 3 Randomized Clinical TrialAnand Swaminath, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|November 23, 2025
Quality of Life of Stereotactic Versus Hypofractionated Radiation Therapy for Inoperable Stage I Non-Small Cell Lung Cancer: Results From the LUSTRE TrialQirui Hou, Sameer Parpia, Marcin Wierzbicki, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2024
Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP TrialDevin Schellenberg, Zsolt Gabos, Adele Duimering, et al.
Pageof 4